---
figid: PMC7810527__ECAM2021-8819245.005
figlink: pmc/articles/PMC7810527/figure/fig5/
number: Figure 5
caption: The NAFLD pathway enriched according to both SZ and NAFLD targets. The orange
  box marks the potential targets of SZ.
pmcid: PMC7810527
papertitle: A Study on the Therapeutic Efficacy of San Zi Yang Qin Decoction for Non-Alcoholic
  Fatty Liver Disease and the Underlying Mechanism Based on Network Pharmacology.
reftext: Yiping Li, et al. Evid Based Complement Alternat Med. 2021;2021:8819245.
pmc_ranked_result_index: '54134'
pathway_score: 0.9335067
filename: ECAM2021-8819245.005.jpg
figtitle: NAFLD pathway enriched according to both SZ and NAFLD targets
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7810527__ECAM2021-8819245.005.html
  '@type': Dataset
  description: The NAFLD pathway enriched according to both SZ and NAFLD targets.
    The orange box marks the potential targets of SZ.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GIF
  - AKT2
  - AKT3
  - AKT1
  - LITAF
  - PPARA
  - PPARG
  - PPARD
  - FAM126A
  - TNF
  - FOS
  - FOSB
  - FOSL2
  - JUN
  - JUNB
  - FOSL1
  - JUND
  - Oxyserol
  - Glucose
  - Fatty acid
  - Acyl-CoA
  - Non-alcoholic fatty liver disease
  - steatosis
  - Glucose uptalke
  - steatohepatitis
  - Fibrosis
  - Cirrhosis
genes:
- word: INF
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Simple
  symbol: SIMPLE
  source: hgnc_alias_symbol
  hgnc_symbol: LITAF
  entrez: '9516'
- word: PPAR
  symbol: PPAR
  source: bioentities_symbol
  hgnc_symbol: PPARA
  entrez: '5465'
- word: PPAR
  symbol: PPAR
  source: bioentities_symbol
  hgnc_symbol: PPARG
  entrez: '5468'
- word: PPAR
  symbol: PPAR
  source: bioentities_symbol
  hgnc_symbol: PPARD
  entrez: '5467'
- word: HCC
  symbol: HCC
  source: hgnc_alias_symbol
  hgnc_symbol: FAM126A
  entrez: '84668'
- word: TNF-a
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: TNF-a
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
chemicals:
- word: Oxyserol
  source: ''
  identifier: ''
- word: Glucose
  source: MESH
  identifier: D005947
- word: Fatty acid
  source: MESH
  identifier: D005227
- word: Acyl-CoA
  source: MESH
  identifier: D000214
diseases:
- word: Non-alcoholic fatty liver disease
  source: MESH
  identifier: D065626
- word: steatosis
  source: MESH
  identifier: D005234
- word: Glucose uptalke
  source: MESH
  identifier: D018149
- word: steatohepatitis
  source: MESH
  identifier: D005234
- word: Fibrosis
  source: MESH
  identifier: D005355
- word: Cirrhosis
  source: MESH
  identifier: D005355
---
